CSL Limited (OTCMKTS:CSLLY) Short Interest Update

CSL Limited (OTCMKTS:CSLLY) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 11,800 shares, an increase of 151.1% from the December 15th total of 4,700 shares. Based on an average daily trading volume, of 159,800 shares, the days-to-cover ratio is currently 0.1 days.

CSL Price Performance

Shares of CSLLY traded up $0.39 during mid-day trading on Wednesday, hitting $87.26. 269,487 shares of the company’s stock were exchanged, compared to its average volume of 90,010. The firm has a fifty day moving average of $89.40 and a two-hundred day moving average of $96.63. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.97 and a current ratio of 2.18. CSL has a twelve month low of $83.31 and a twelve month high of $109.00.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.